FTC

FTC seeks more information on Boston Scientific's $3.7 bln Axonics deal
Reuters
Thu, 04/4/24 - 10:57 am
Boston Scientific
Medtech
FTC
M&A
Axonics
FTC weighs in on Teva's inhaler litigation against Amneal amid far-reaching patent crackdown
Fierce Pharma
Mon, 03/25/24 - 11:25 am
FTC
patents
legal
Teva Pharmaceutical
Amneal
Congressional lawmakers strike back at Biden admin's 'march-in' proposal to corral drug costs
Fierce Pharma
Fri, 02/23/24 - 10:24 am
Joe Biden
FTC
march-in rights
congress
drug pricing
AbbVie’s Cerevel deal hits an uncommon roadblock
BioPharma Dive
Wed, 02/21/24 - 11:10 am
AbbVie
Cerevel Therapeutics
M&A
FTC
antitrust
FTC probing middlemen's role in drug shortages
Axios
Fri, 02/16/24 - 11:23 am
FTC
HHS
drug shortages
PBMs
generics
supply chain
FTC and HHS Launch Probe of Ongoing Generic Drug Shortages
BioSpace
Wed, 02/14/24 - 06:41 pm
drug shortages
FTC
HHS
generics
FTC’s Misguided Antitrust Regulation Threatens Pharma Innovation
Forbes
Wed, 02/14/24 - 11:25 am
FTC
antitrust
innovation
FTC calls for 'expansive and flexible' use of march-in rights to rein in
Fierce Pharma
Tue, 02/6/24 - 11:35 pm
FTC
march-in rights
patents
The FTC is attacking drugmakers’ ‘patent thickets’
Medical Marketing and Media
Wed, 01/31/24 - 10:24 pm
FTC
patents
patent thickets
Failed Illumina and Sanofi Deals Shine Light on FTC Antitrust Crackdown
BioSpace
Wed, 12/20/23 - 06:41 pm
Illumina
Grail
Sanofi
Maze Therapeutics
FTC
M&A
antitrust
FTC, DOJ finalize guidelines for reviewing anticompetitive mergers
Fierce Healthcare
Wed, 12/20/23 - 09:49 am
FTC
DOJ
antitrust
regulatory
FTC, in unusual move, leads Sanofi to terminate a drug research deal
BioPharma Dive
Tue, 12/12/23 - 10:43 pm
FTC
Sanofi
R&D
Maze Therapeutics
Sanofi Drops Acquisition of Maze’s Pompe Disease Drug After FTC Challenge
BioSpace
Tue, 12/12/23 - 09:57 am
Ssanofi
Maze Therapeutics
Pompe disease
FTC
legal
FTC warns pharma companies on excessive drug patenting
Medical Marketing and Media
Fri, 12/8/23 - 10:05 am
FTC
AbbVie
AstraZeneca
Teva Pharmaceutical
patents
AbbVie CEO Gonzalez brushes off FTC concerns for Cerevel buy: 'This acquisition is not anti-competitive.'
Fierce Biotech
Thu, 12/7/23 - 11:08 pm
AbbVie
Cerevel Therapeutics
M&A
Richard Gonzalez
FTC
anticompetitive practices
FTC chief gears up for a showdown with private equity
Medical Marketing and Media
Thu, 11/30/23 - 11:18 pm
FTC
private equity
With filing in Sanofi and Mylan insulin lawsuit, FTC amps up scrutiny on pharma's patent tactics
Fierce Pharma
Tue, 11/21/23 - 10:54 pm
Sanofi
Mylan
legal
FTC
insulin
diabetes
AbbVie, AstraZeneca, Boehringer and more face FTC's ire for 'improper' patent listings
Fierce Pharma
Tue, 11/7/23 - 11:08 pm
FTC
Orange Book
patents
AbbVie
AstraZeneca
Boehringer Ingelheim
Amgen Completes $27.8B Horizon Acquisition Following FTC Challenge
BioSpace
Fri, 10/6/23 - 11:37 am
Amgen
Horizon Therapeutics
FTC
M&A
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans
BioSpace
Wed, 09/20/23 - 08:59 am
Amgen
Horizon Therapeutics
FTC
antitrust
M&A

Pages